Pre-earnings options volume in Sellas Life Sciences (SLS) is normal with calls leading puts 16:1. Implied volatility suggests the market is anticipating a move near 4.6%, or 24c, after results are released. Median move over the past eight quarters is 6.0%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLS:
- Sellas Life Sciences call volume above normal and directionally bullish
- Largest borrow rate increases among liquid names
- BUY Rating on SELLAS: Pivotal REGAL Phase 3 Progress, Expanding AML Pipeline, and Cash Runway into 2027 Support Upside Potential
- Sellas Life Sciences files automatic mixed securities shelf
- Sellas Life Sciences price target raised to $10 from $7.50 at Alliance Global